Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • Target Advancement Program, 2022
    Alpha-synuclein Aggregation in the Brainstem: Developing a Model and Discovering a New Biomarker for Parkinson Disease

    Study Rationale: Abnormal accumulation of alpha-synuclein (a neuronal protein) in distinct regions of the brain is a well known feature in Parkinson’s disease (PD). A sizeable number of people with PD...

  • Target Advancement Program, 2022
    Development of an Antibody for Isolating Mitochondria from Preclinical Models and Individuals with Parkinson’s Disease

    Study Rationale: Previous research has demonstrated that mitochondria — the energy-generating centers in the cell — are impaired in the brains of people with Parkinson’s disease (PD). However, the...

  • Spring 2022 RFA: Target Advancement Program - Tool Generation, 2022
    Design and testing of a FRET sensor for Parkin activity

    Study Rationale: Parkin is a protein that is encoded by a gene which is frequently mutated in Parkinson’s disease. It is known to be involved in getting rid of damaged mitochondria in cells and this...

  • Proof-of-Concept Testing of PD Therapeutics, 2022
    Therapeutic Targeting of Mitochondrial Biogenesis to Address Parkinson’s Disease

    Study Rationale: Parkinson’s disease (PD) is a complex disorder involving the degeneration of specific brain cells that lead to severe impairments in movement and cognition. Although the exact cause...

  • Research Grant, 2022
    Shoring Up a Medical Chemistry Approach to Treating Parkinson’s Disease: The Bridge Initiative

    Study Rationale: The proteins parkin and GCase show a strong genetic link to Parkinson’s disease (PD) and are key players of biological pathways often disrupted in the disorder. This connection makes...

  • Parkinson’s Pathway Molecular Data Analysis Program, 2022
    Investigating the Role of Repeat Expansions and Mitochondrial Dysfunction in Parkinson’s Disease

    Study Rationale: Both genetic mutations and exposure to environmental factors contribute to Parkinson’s disease (PD). Genetic risk for someone with PD could be due to multiple genes, different types...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.